Literature DB >> 30272657

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer.

Yin Wang1, Mark L Day2, Diane M Simeone3, Phillip L Palmbos4.   

Abstract

Bladder cancer is a significant health problem. It is estimated that more than 16,000 people will die this year in the United States from bladder cancer. While 75% of bladder cancers are non-invasive and unlikely to metastasize, about 25% progress to an invasive growth pattern. Up to half of the patients with invasive cancers will develop lethal metastatic relapse. Thus, understanding the mechanism of invasive progression in bladder cancer is crucial to predict patient outcomes and prevent lethal metastases. In this article, we present a three-dimensional cancer invasion model which allows incorporation of tumor cells and stromal components to mimic in vivo conditions occurring in the bladder tumor microenvironment. This model provides the opportunity to observe the invasive process in real time using time-lapse imaging, interrogate the molecular pathways involved using confocal immunofluorescent imaging and screen compounds with the potential to block invasion. While this protocol focuses on bladder cancer, it is likely that similar methods could be used to examine invasion and motility in other tumor types as well.

Entities:  

Mesh:

Year:  2018        PMID: 30272657      PMCID: PMC6235181          DOI: 10.3791/58345

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

Review 1.  Review: BBN as an urothelial carcinogen.

Authors:  C Vasconcelos-Nóbrega; A Colaço; C Lopes; P A Oliveira
Journal:  In Vivo       Date:  2012 Jul-Aug       Impact factor: 2.155

2.  A novel 3-dimensional culture system as an in vitro model for studying oral cancer cell invasion.

Authors:  Hai S Duong; Anh D Le; Qunzhou Zhang; Diana V Messadi
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  Actin polymerization. The mechanism of action of cytochalasin D.

Authors:  D W Goddette; C Frieden
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

4.  A new in vitro assay for quantitating tumor cell invasion.

Authors:  L A Repesh
Journal:  Invasion Metastasis       Date:  1989

5.  Collective invasion in breast cancer requires a conserved basal epithelial program.

Authors:  Kevin J Cheung; Edward Gabrielson; Zena Werb; Andrew J Ewald
Journal:  Cell       Date:  2013-12-12       Impact factor: 41.582

Review 6.  Bladder Cancer: Diagnosis and Treatment.

Authors:  Katharine C DeGeorge; Harry R Holt; Stephanie C Hodges
Journal:  Am Fam Physician       Date:  2017-10-15       Impact factor: 3.292

Review 7.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Authors:  Margaret A Knowles; Carolyn D Hurst
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

8.  Collagen gel three-dimensional matrices combined with adhesive proteins stimulate neuronal differentiation of mesenchymal stem cells.

Authors:  Jae Ho Lee; Hye-Sun Yu; Gil-Su Lee; Aeri Ji; Jung Keun Hyun; Hae-Won Kim
Journal:  J R Soc Interface       Date:  2011-01-19       Impact factor: 4.118

9.  Mechanistic adaptability of cancer cells strongly affects anti-migratory drug efficacy.

Authors:  Wei Sun; Chwee Teck Lim; Nicholas Agung Kurniawan
Journal:  J R Soc Interface       Date:  2014-10-06       Impact factor: 4.118

Review 10.  Movers and shakers: cell cytoskeleton in cancer metastasis.

Authors:  C M Fife; J A McCarroll; M Kavallaris
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more
  1 in total

1.  ATDC mediates a TP63-regulated basal cancer invasive program.

Authors:  Phillip L Palmbos; Yin Wang; Armand Bankhead Iii; Alan J Kelleher; Lidong Wang; Huibin Yang; McKenzie L Ahmet; Erica R Gumkowski; Samuel D Welling; Brian Magnuson; Jacob Leflein; Guadalupe Lorenzatti Hiles; Ethan V Abel; Michele L Dziubinski; Sumithra Urs; Mark L Day; Mats E Ljungman; Diane M Simeone
Journal:  Oncogene       Date:  2019-01-14       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.